Verizon Communications (VZ) surged nearly 12% after a robust Q4 2023 report, record postpaid growth, and a major share repurchase program. The telecom giant's confident 2026 outlook and strategic acquisition of Frontier assets signal a potential pivot, though questions about debt and valuation persist.
As the TSX rides a wave of positive earnings momentum, adventurous investors are turning their gaze to the penny stock arena. We analyze three micro-cap companies—Automotive Finco, Aurora Spine, and Wilton Resources—that are generating buzz, weighing their potential against significant financial risks.
In his first interview as Executive Chairman, Gildo Zegna outlines a strategy of agility and direct consumer engagement to navigate global uncertainties, as the group reports resilient 2025 results driven by its flagship brand.
London-based investment firm Robocap Asset Management has liquidated its entire $5.1 million position in NICE Ltd., as the cloud software company navigates a challenging strategic shift to AI-centric solutions against a backdrop of significant stock decline.
A newly disclosed DHS document reveals Palantir is providing generative AI to U.S. Immigration and Customs Enforcement to sort and summarize enforcement tips, highlighting the firm's deepening government integration just days before its Q4 earnings release.
Investment firm Hussman Strategic Advisors has significantly increased its stake in Etsy, signaling strong conviction in the e-commerce platform's recovery strategy and growth potential, particularly from its Depop subsidiary.
Following a sharp post-earnings sell-off, Intel CFO David Zinsner made a substantial open-market purchase of company stock, a move seen as a strong vote of confidence even as Wall Street analysts remain divided on the chipmaker's turnaround prospects.
Investment firm Monument Capital Management has completely exited its position in Grand Canyon Education, selling 19,133 shares. The move comes as the education services provider navigates legal challenges and market underperformance.
While the energy sector retrenched amid falling crude prices, ExxonMobil executed a massive $20 billion share repurchase program in 2025, underlining its financial muscle and commitment to shareholder returns. The oil giant also reported earnings that beat estimates, driven by record production in the Permian Basin and Guyana, even as it takes a hardline stance on reinvesting in Venezuela.
Despite its leadership in high-demand defense sectors like drones and hypersonics, Kratos Defense & Security's shares face sustained pressure as investors question its sky-high valuation and cash flow.
The Swiss watchmaker reported a dip in 2025 profits amid currency headwinds and strategic investments, but forecasts a return to broad-based growth next year, buoyed by robust second-half sales and strong performance in key markets like the Americas.
While 3M shares have significantly underperformed the broader market and its industrial peers over the past year, Wall Street maintains a cautiously optimistic stance, betting on the diversified giant's long-term recovery and earnings resilience.
Spanish healthtech startup Biorce has closed a substantial Series A round, backed by prominent venture capital and angel investors, to scale its AI-driven clinical trial solution, Aika, internationally amid a tightening regulatory landscape.
Life sciences and diagnostics firm Revvity (RVTY) closed 2025 with results surpassing internal targets, driven by robust diagnostics performance. While management provided initial 2026 guidance, it remains conservative, banking on market stabilization rather than a broad recovery.
Hess Midstream Partners (HESM) capped off 2025 with robust operational results and the completion of its core infrastructure build-out. Management now signals a sharp pivot towards capital discipline, forecasting significantly lower spending through 2028 to fuel growing shareholder returns, even as severe winter weather tempers near-term volume expectations.
Synthetic biology leader Twist Bioscience reported strong Q1 FY2026 results, with revenue climbing 17% year-over-year to $103.7 million. Management highlighted accelerating demand from AI-powered drug discovery and reiterated its path to adjusted EBITDA breakeven by Q4 FY2026.
IDEXX Laboratories (IDXX) reported robust double-digit growth for Q4 2025, driven by record placements of its premium diagnostic instruments and expanding test utilization. While acknowledging persistent softness in U.S. veterinary visit volumes, the company outlined a confident initial 2026 forecast, banking on its innovation pipeline and the transformative impact of its inVue Dx system.
A notable investment fund has significantly reduced its position in Sirius XM Holdings, reflecting growing concerns over the audio giant's growth trajectory and competitive challenges, even as the company maintains strong cash generation.
A new round of U.S.-mediated negotiations between Russia and Ukraine is scheduled for this week in Abu Dhabi, officials confirm, as battlefield violence and long-range attacks continue to shape the diplomatic landscape.
Capital Management Corp sold $5.8 million worth of Nexstar Media Group shares, reducing its position in the broadcaster after a year of strong outperformance. The move highlights investor balancing acts amid cyclical advertising headwinds and long-term election cycle potential.
